Skip to main content
Premium Trial:

Request an Annual Quote

EdgeBio Named CSP for Agilent's SureSelect

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today said that EdgeBio has been appointed a Certified Service Provider for the firm's SureSelect Target Enrichment System for next-generation sequencing.

Specifically, the firms said that Gaithersburg, Md.-based EdgeBio achieved SureSelect CSP status for the Life Technologies SOLiD 4 sequencing platform. Agilent's SureSelect also supports the Illumina genome Analyzer and HiSeq platforms, and the Roche 454 Life Sciences platform.

The SureSelect was launched in early 2009 and enables researchers to focus on genomic regions of interest rather than sequencing an entire genome.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.